In the present study, we assessed the impact of proposing a watch-and-wait approach rather than the standard early adjuvant radio-chemotherapy following maximal safe function-based awake resection of supratentorial grade 3 gliomas, IDH-mutant in selected low-risk patients. The gene discussed is IDH1; the disease is glioma.